SI
ONCY

Seeds Investor’s Oncolytics Biotech ONCY Stock Holding History

Seeds Investor’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$263K Hold
258,306
– – 0.04% 295
2025
Q4 		$226K Hold
258,306
– – 0.04% 242
2025
Q3 		$362K Buy
258,306
+34,539
+15% +$38.7K 0.08% 160
2025
Q2 		$173K Buy
223,767
+33,826
+18% +$17.9K 0.04% 245
2025
Q1 		$104K Hold
189,941
– – 0.03% 245
2024
Q4 		$174K Hold
189,941
– – 0.05% 268
2024
Q3 		$165K Hold
189,941
– – 0.06% 256
2024
Q2 		$188K Buy
+189,941
New +$207K 0.1% 206

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Seeds Investor's ONCY Position: Q1 2026 in Review

Seeds Investor held its Oncolytics Biotech (ONCY) position steady in Q1 2026 at 258,306 shares worth $263K. The position accounts for 0.04% of the portfolio, ranked #295.

Seeds Investor first reported a position in ONCY in Q2 2024 and has held it in 8 quarters since. The position peaked at $362K in Q3 2025. 59 funds tracked by Wall St. Rank hold ONCY as of Q1 2026.

  • Seeds Investor held 258,306 shares of Oncolytics Biotech worth $263K as of Q1 2026.
  • Seeds Investor left its Oncolytics Biotech share count unchanged in Q1 2026.
  • Oncolytics Biotech made up 0.04% of Seeds Investor's portfolio in Q1 2026, its #295 holding.
  • Seeds Investor first reported a position in Oncolytics Biotech in Q2 2024 and has held it in 8 quarters since.
  • Seeds Investor's Oncolytics Biotech position peaked at $362K in Q3 2025.
  • 59 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2026.

Based on Seeds Investor's 13F filing for Q1 2026, filed 11 May 2026.